글로벌 전립선암 진단 시장 – 2031년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Medical Devices Global Prostate Cancer Diagnostics Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

글로벌 전립선암 진단 시장 – 2031년까지의 산업 동향 및 예측

  • Medical Devices
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

Global Prostate Cancer Diagnostics Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
 2024 –2031
Diagram 시장 규모(기준 연도)
 USD 4,196.09 Million
Diagram 시장 규모(예측 연도)
 USD 9,327.01 Million
Diagram 연평균 성장률
 %
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
잠금 해제 요청

>글로벌 전립선암 진단 시장, 제품 유형별(기구, 시약 및 소모품, 액세서리), 진단 유형(예비 선별 검사, 확인 검사), 연령대(성인, 소아, 노인), 유형(전립선 선암, 소세포 암, 기타), 병기(국소적 전립선암, 재발/진행성 전립선암, 거세 저항성 전립선암(전이성, 비전이성), 샘플 유형(혈액, 조직, 소변, 기타), 최종 사용자(독립적인 진단 실험실, 병원, 암 연구소, 진료소, 외래 수술 센터, 기타), 유통 채널(직접 입찰, 소매 판매) - 업계 동향 및 2031년까지의 예측.

전립선암 진단 시장

전립선암 진단 시장 분석 및 규모   

전립선암 진단은 질병의 조기 발견과 효율적인 관리에 중요한 역할을 합니다. 여기에는 기구, 시약 및 소모품, 액세서리 사용이 포함됩니다. PSA 검사는 전립선암의 가장 흔한 예비 진단으로, 암을 발견하기 위해 확인 검사가 필요할 수도 있고 그렇지 않을 수도 있습니다.

전립선암 진단을 사용하면 국소 단계에서 전립선암을 조기에 발견하는 데 도움이 되고, 이를 통해 사람들이 효율적인 건강 관리를 달성하는 데 도움이 되는 등 여러 가지 이점이 있습니다. 전립선암 진단을 사용하는 것은 전 세계적으로 인기를 얻고 있으며, 특히 의료 기준이 높아지는 신흥 시장에서 인기가 높습니다.

Data Bridge Market Research는 2023년에 4,196.09백만 달러였던 글로벌 전립선암 진단 시장이 2031년까지 9,327.01백만 달러에 도달할 가능성이 높으며 예측 기간 동안 10.5%의 CAGR을 기록할 것으로 분석했습니다. "성인"은 성인 남성의 암 유병률이 더 높기 때문에 시장에서 연령대 세그먼트에서 가장 큰 시장 점유율을 차지합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 적용 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

전립선암 진단 시장 범위 및 세분화

보고서 메트릭

세부

예측 기간

2024년부터 2031년까지

기준 연도

2023

역사적 연도

2022 (2016-2021년까지 사용자 정의 가능)

양적 단위

매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨

다루는 세그먼트

By Product Type (Instruments, Reagents & Consumables, Accessories), Diagnostics Type (Preliminary Screening Tests, Confirmatory Tests), Age Group (Adult, Pediatric, Geriatrics), Type (Prostatic Adenocarcinoma, Small Cell Carcinoma, Others), Stage (Localized Prostate Cancer, Recurrent/Advanced Prostate Cancer, Castration-Resistant Prostate Cancer (Metastatic, Non-Metastatic), Sample Type (Blood, Tissue, Urine, Others), End Users (Independent Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Retail Sales)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Belgium, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.

Market Players Covered

F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), HUMASIS (South Korea), Teco Diagnostics (U.S.), Hologic Inc. (U.S.), Accuquik Test Kits (U.S.), MDxHealthcare (Belgium), Abbott (U.S.), Siemens Healthcare GmbH (Germany), OPKO Health Inc. (U.S.), Myriad Genetics, Inc. (U.S.), DiaSorin S.p.A (Italy), Beckman Coulter, Inc. (a subsidiary of Danaher) (U.S.), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation) (U.S.), bioMérieux SA (France), Metamark Genetics, Inc. (U.S.), Prostatype Genomics (Switzerland), Fujirebio (Belgium), Proteomedix (Switzerland), Eurolyser Diagnostica GmbH (Austria)

Market Opportunities
  • Advancements in biomarker research
  • Focus on personalized medicine

Market Definition

Prostate cancer diagnosis involves a combination of medical history assessment, physical examination, and specific diagnostic tests. The initial steps often include a digital rectal exam (DRE) to assess the prostate gland for abnormalities. Blood tests, such as the prostate-specific antigen (PSA) test, measure elevated levels of a protein associated with prostate conditions, including cancer. Imaging studies like ultrasound, magnetic resonance imaging (MRI), or computed tomography (CT) scans may be employed to visualize the prostate and surrounding tissues for signs of cancer. A biopsy, typically guided by imaging, involves the removal of tissue samples from the prostate for laboratory analysis to confirm the presence of cancerous cells and determine the cancer's aggressiveness. The combined results of these assessments help physicians formulate an accurate diagnosis and determine an appropriate course of treatment for the patient.

Global Prostate Cancer Diagnostics Market Dynamics

Drivers

  • Increasing Aging Population

The demographic shift towards an aging population is a significant driver for the prostate cancer diagnostics market. Prostate cancer predominantly affects older men, and as the proportion of elderly individuals rises globally, there is a natural increase in the number of people at risk for prostate cancer. The elderly demographic often undergoes routine screenings and diagnostic tests, contributing to the overall demand for prostate cancer diagnostics.

  • Rising Incidence of Prostate Cancer

The incidence of prostate cancer has been steadily increasing, making it a major driver for diagnostic market growth. Factors such as lifestyle changes, environmental influences, and genetic predispositions contribute to the higher occurrence of prostate cancer cases. The heightened awareness of the disease and the importance of early detection have led to more individuals seeking diagnostic evaluations, further fuelling the demand for advanced and accurate diagnostic tools in the market.

Opportunities

  • Advancements in Biomarker Research

Ongoing exploration of new biomarkers associated with prostate cancer, such as genetic mutations, circulating tumor cells, and specific proteins, creates opportunities for the development of highly sensitive and specific diagnostic tests. As researchers uncover more nuanced details about the molecular signatures of prostate cancer, diagnostic companies can leverage this knowledge to enhance the precision and reliability of diagnostic tools, ultimately improving early detection rates and patient outcomes.

  • Focus on Personalized Medicine

The increasing emphasis on personalized medicine in prostate cancer diagnostics presents an opportunity to tailor diagnostic approaches based on individual patient characteristics. Integrating genetic profiling, molecular analysis, and patient-specific factors allows for a more targeted and effective diagnostic strategy. This personalized approach not only enhances the accuracy of prostate cancer diagnosis but also opens avenues for the development of customized treatment plans, aligning with the broader trend in healthcare towards more individualized and patient-centered care.

Restraints/Challenges

  • Limited Specificity of Biomarkers

The challenge lies in the fact that some biomarkers used in prostate cancer diagnostics may lack the specificity needed to accurately distinguish between benign conditions and aggressive forms of the disease. This limitation can result in false-positive results, leading to unnecessary invasive procedures and overtreatment. Improving the specificity of biomarkers is crucial for enhancing the precision of diagnostic tests and ensuring more informed clinical decision-making.

  • Invasive Nature of Diagnostic Procedures

Invasive diagnostic procedures, particularly prostate biopsies, pose a significant challenge due to associated discomfort, potential side effects, and the risk of infection. Patient apprehension and reluctance to undergo these procedures can result in delayed or avoided diagnostic evaluations, potentially leading to missed opportunities for early cancer detection. Developing less invasive or non-invasive diagnostic alternatives is essential to encourage broader patient participation and improve the overall patient experience in prostate cancer diagnostics.

This prostate cancer diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the prostate cancer diagnostics Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In October, 2020 Siemens Healthcare GmbH announced that they have launched Biograph Vision Quadra Extended Axial FoV PET/CT Scanner. This scanner is the industry’s most sensitive extended field view scanner designed for clinical and research purposes. The product is of high clinical use and will increase the demand for cancer diagnostic procedure and will increase the revenue for the company
  • In March, 2020 DiaSorin S.p.A and TTP plc, a leading independent technology and product development company announced that they have signed an exclusive licensing and technology transfer agreement under which DiaSorin will gain access to TTP’s Puckdx TM, a flexible and low-cost platform for the automation of sample-to-answer diagnostic assays. This will increase the advancement in diagnostic business profile for the company and will help in future business development

Global Prostate Cancer Diagnostics Market Scope

The prostate cancer diagnostics market is segmented on the basis of product type, diagnostics type, age group, type, stage, sample type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Instruments
  • Reagents & Consumables
  • Accessories

Diagnostics Type

  • Preliminary Screening Tests
  • Confirmatory Tests

Age Group

  • Adult
  • Pediatric
  • Geriatrics

Type

  • Prostatic Adenocarcinoma
  • Small Cell Carcinoma
  • Others

Stage

  • Localized Prostate Cancer
  • Recurrent/Advanced Prostate Cancer
  • 거세 저항성 전립선암(전이성 및 비전이성 )

샘플 유형

  • 피
  • 조직
  • 오줌
  • 기타

최종 사용자

  • 독립 진단 연구소
  • 병원
  • 암 연구소
  • 클리닉
  • 외래 수술 센터
  • 기타

유통 채널

  • 직접 입찰
  • 소매 판매

글로벌 전립선암 진단 시장 지역 분석/통찰력

전립선암 진단 시장을 분석하고, 위에 참조된 대로 제품 유형, 진단 유형, 연령대, 유형, 단계, 샘플 유형, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코, 독일, 영국, 프랑스, ​​이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 기타 유럽, 일본, 중국, 호주, 인도, 한국, 싱가포르, 인도네시아, 태국, 말레이시아, 필리핀, 기타 아시아 태평양, 브라질, 아르헨티나, 기타 남미, 사우디 아라비아, 남아프리카, UAE, 이스라엘, 이집트, 기타 중동 및 아프리카입니다.

북미가 시장을 주도할 것으로 예상되며, 이 지역의 의료비 지출이 높고 전립선암 진단 검사를 실시할 수 있는 의료 시설이 잘 갖춰져 있기 때문입니다.

전립선암 유병률 증가로 인해 아시아 태평양 지역은 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

전립선암 진단 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 전립선암 진단 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 전립선암 진단 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 글로벌 전립선암 진단 시장 점유율 분석

전립선암 진단 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 전립선암 진단 시장과 관련된 회사의 초점에만 관련이 있습니다.

전립선암 진단 시장에서 활동하는 주요 기업은 다음과 같습니다.

  • F. 호프만-라 로슈 유한회사(스위스)
  • ACON 연구소, Inc. (미국)
  • HUMASIS(한국)
  • 테코 다이어그노스틱스(미국)
  • 홀로직 주식회사(미국)
  • Accuquik 테스트 키트(미국)
  • MDxHealthcare(벨기에)
  • 애벗(미국)
  • 지멘스 헬스케어 GmbH(독일)
  • OPKO Health Inc. (미국)
  • Myriad Genetics, Inc. (미국)
  • DiaSorin SpA(이탈리아)
  • Beckman Coulter, Inc. (Danaher의 자회사) (미국)
  • Genomic Health, Inc. (Exact Sciences Corporation의 자회사) (미국)
  • bioMérieux SA(프랑스)
  • 메타마크 제네틱스 주식회사(미국)
  • Prostatype Genomics(스위스)
  • 후지레비오(벨기에)
  • Proteomedix(스위스)
  • Eurolyser Diagnostica GmbH(오스트리아)

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end users coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. COMPARATIVE ANALYSIS WITH PARENT MARKET
  6. REGULATORY FRAMEWORK: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    1. REGULATORY SCENARIO IN THE U.S.
    2. REGULATORY SCENARIO IN EUROPEAN UNION
    3. REGULATORY SCENARIO IN JAPAN
    4. REGULATORY SCENARIO IN CHINA
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF PROSTATE CANCER
      2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
      3. INCREASE IN GERIATRIC POPULATION
      4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
      5. DISEASE CAUSING PROSTATE CANCER
    2. RESTRAINTS
      1. CONTROVERSY RELATED TO PSA TESTING
      2. HIGH COST OF DIAGNOSTICS PROCEDURE
      3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    3. OPPORTUNITIES
      1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
      2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
      3. GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
      4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
    4. Challenges
      1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
      2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
      3. INACCURATE DIAGNOSIS RESULTS
  8. IMPACT OF COVID-19 ON GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
    5. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    6. CONCLUSION
  9. global PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
    1. overview
    2. reagents & consumables
    3. instruments
    4. accessories
  10. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
    1. overview
    2. preliminary screening tests
      1. Prostate-Specific Antigen (PSA) Test
      2. Digital Rectal Exam (DRE) Test
    3. Confirmatory Tests
      1. PCA3 Test
      2. biopsy
      3. imaging tests
        1. ULTRASOUND
        2. MAGNETIC RESONANCE IMAGING (MRI)
          1. MULTIPARAMETRIC MRI
          2. MRI FUSION-GUIDED PROSTATE BIOPSY
        3. CT SCAN
        4. BONE SCAN
        5. PET/CT SCAN
      4. biomarker
        1. RNA BIOMARKERS
        2. DNA BIOMARKERS
        3. PROTEIN BIOMARKERS
  11. Global prostate cancer diagnostics Market, By type
    1. overview
    2. PROSTATIC ADENOCARCINOMA
    3. small cell carcinoma
    4. Others
  12. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
    1. overview
    2. geriatrics
    3. adult
    4. Pediatric
  13. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
    1. overview
    2. LOCALIZED PROSTATE CANCER
    3. RECURRENT/ADVANCED PROSTATE CANCER
    4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
  14. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
    1. overview
    2. Blood
    3. tissue
    4. urine
    5. others
  15. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
    1. overview
    2. Independent Diagnostic Laboratories
    3. hospitals
    4. Clinics
    5. Ambulatory Surgical Centers
    6. Cancer Research Institutes
    7. others
  16. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
    1. overview
    2. direct tender
    3. retail sales
  17. GLOBAL Prostate cancer diagnostics maRKET, BY GEOGRAPHY
    1. OVERVIEW
    2. NORTH AMERICA
      1. u.s.
      2. canada
      3. mexico
    3. europe
      1. GERMANY
      2. FRANCE
      3. u.k.
      4. iTALY
      5. SPAIN
      6. RUSSIA
      7. SWITZERLAND
      8. NETHERLANDS
      9. TURKEY
      10. bELGIUM
      11. REST OF EUROPE
    4. Asia - Pacific
      1. CHINA
      2. JAPAN
      3. India
      4. Australia
      5. SOUTH KOREA
      6. SINGAPORE
      7. THAILAND
      8. MALAYSIA
      9. INDONESIA
      10. Philippines
      11. REST OF ASIA - PACIFIC
    5. south AMERICA
      1. BRAZIL
      2. ARGENTINa
      3. rest of south america
    6. Middle east & africa
      1. SOUTH AFRICA
      2. saudi arabia
      3. uAE
      4. iSRAEL
      5. EGYPT
      6. REST OF MIDDLE EAST & AFRICA
  18. Global Prostate cancer diagnostics market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  19. SWOT
  20. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHot
      2. REVENUE ANALYSIS
      3. company share analysis
      4. product Portfoli0
      5. RECENT DEVELOPMENTs
    2. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. siemens HEALTHCARE gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. OPko HEALTH INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Beckman Coulter, Inc. (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. ACCUQUIK TEST KITS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. acon laboratories inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. Diasorin s.p.a
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLI0
      4. RECENT DEVELOPMENTS
    10. Eurolyser Diagnostica GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. FUJIREBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI
      3. RECENT DEVELOPMENTS
    12. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. HOLOGIC, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. HUMASIS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. MDXHEALTHCARE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Metamark genetics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI0
      3. RECENT DEVELOPMENTS
    17. Myraid genetics, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. Prostatype Genomics
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. PROTEOMEDIX
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. TECO DIAGNOSTICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  21. questionnaire
  22. related reports

표 목록

TABLE 1 CATEGORIZATION UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA '88) OF 1988

TABLE 2 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER

TABLE 3 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (USD Million)

TABLE 4 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (UNits)

TABLE 5 global reagents & consumables in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 6 globaL instruments in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 7 globaL accessories in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 8 global PROSTATE CANCER DIAGNOSTICS Market, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)

TABLE 9 global preliminary screening tests in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 10 global Confirmatory Testsin PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 11 Global prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 12 Global prostatic Adenocarcinomas in prostate cancer diagnostics market, By Type 2019-2028 (USD Million), By Region

TABLE 13 Global small cell carcinoma in prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 14 Global Others in prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 15 global PROSTATE CANCER DIAGNOSTICS Market, By age group 2019-2028 (USD Million)

TABLE 16 global geriatrics in PROSTATE CANCER DIAGNOSTICS Market, By region 2019-2028 (USD Million)

TABLE 17 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)

TABLE 18 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)

TABLE 19 Global Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 20 Global Localized Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global Recurrent/Advanced Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 22 Global Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 24 Global Blood in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 25 Global Tissue in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global Urine in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 27 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 28 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 29 Global Independent Diagnostic Laboratories in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 31 Global Clinics in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 32 Global Ambulatory Surgical Centers in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 33 Global Cancer Research Institutes in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 34 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 35 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 36 Global Direct Tender in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 37 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 38 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 North America PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 40 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 41 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 42 North America Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 43 North America Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 44 North America Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 45 North America Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 46 North America Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 47 North America Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 48 North America Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 49 North America Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 50 North America Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 51 North America Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 52 North America Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 53 North America Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 54 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 55 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 56 U.S. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 57 U.S. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 58 U.S. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 59 U.S. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 60 U.S. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 61 U.S. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 62 U.S. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 63 U.S. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 64 U.S. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 65 U.S. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 66 U.S. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 67 U.S. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 68 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 69 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 70 CANADA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 71 CANADA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 72 CANADA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 73 CANADA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 74 CANADA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 75 CANADA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 76 CANADA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 77 CANADA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 78 CANADA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 79 CANADA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 80 CANADA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 81 CANADA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 83 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 84 MEXICO Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 85 MEXICO Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 86 MEXICO Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 87 MEXICO Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 88 MEXICO Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 89 MEXICO Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 90 MEXICO Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 91 MEXICO Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 92 MEXICO Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 93 MEXICO Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 94 MEXICO Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 95 MEXICO Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 96 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 97 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 98 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 99 EUROPE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 100 EUROPE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 101 EUROPE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 102 EUROPE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 103 EUROPE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 104 EUROPE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 105 EUROPE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 106 EUROPE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 107 EUROPE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 108 EUROPE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 109 EUROPE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 110 EUROPE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 111 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 112 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 113 GERMANY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 114 GERMANY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 115 GERMANY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 116 GERMANY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 117 GERMANY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 118 GERMANY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 119 GERMANY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 120 GERMANY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 121 GERMANY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 122 GERMANY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 123 GERMANY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 124 GERMANY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 125 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 126 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 127 FRANCE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 128 FRANCE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 129 FRANCE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 130 FRANCE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 131 FRANCE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 132 FRANCE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 133 FRANCE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 134 FRANCE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 135 FRANCE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 136 FRANCE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 137 FRANCE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 138 FRANCE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 139 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 140 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 141 U.K. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 142 U.K. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 143 U.K. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 144 U.K. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 145 U.K. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 146 U.K. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 147 U.K. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 148 U.K. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 149 U.K. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 150 U.K. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 151 U.K. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 152 U.K. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 153 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 154 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 155 ITALY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 156 ITALY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 157 ITALY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 158 ITALY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 159 ITALY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 160 ITALY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 161 ITALY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 162 ITALY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 163 ITALY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 164 ITALY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 165 ITALY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 166 ITALY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 167 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 168 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 169 SPAIN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 170 SPAIN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 171 SPAIN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 172 SPAIN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 173 SPAIN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 174 SPAIN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 175 SPAIN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 176 SPAIN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 177 SPAIN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 178 SPAIN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 179 SPAIN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 180 SPAIN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 181 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 182 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 183 RUSSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 184 RUSSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 185 RUSSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 186 RUSSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 187 RUSSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 188 RUSSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 189 RUSSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 190 RUSSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 191 RUSSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 192 RUSSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 193 RUSSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 194 RUSSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 196 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 197 SWITZERLAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 198 SWITZERLAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 199 SWITZERLAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 200 SWITZERLAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 201 SWITZERLAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 202 SWITZERLAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 203 SWITZERLAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 204 SWITZERLAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 205 SWITZERLAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 206 SWITZERLAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 207 SWITZERLAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 208 SWITZERLAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 209 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 210 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 211 NETHERLANDS Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 212 NETHERLANDS Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 213 NETHERLANDS Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 214 NETHERLANDS Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 215 NETHERLANDS Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 216 NETHERLANDS Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 217 NETHERLANDS Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 218 NETHERLANDS Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 219 NETHERLANDS Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 220 NETHERLANDS Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 221 NETHERLANDS Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 222 NETHERLANDS Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 223 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 224 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 225 TURKEY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 226 TURKEY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 227 TURKEY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 228 TURKEY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 229 TURKEY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 230 TURKEY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 231 TURKEY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 232 TURKEY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 233 TURKEY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 234 TURKEY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 235 TURKEY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 236 TURKEY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 237 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 238 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 239 BELGIUM Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 240 BELGIUM Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 241 BELGIUM Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 242 BELGIUM Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 243 BELGIUM Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 244 BELGIUM Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 245 BELGIUM Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 246 BELGIUM Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 247 BELGIUM Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 248 BELGIUM Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 249 BELGIUM Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 250 BELGIUM Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 251 rest of europe Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 252 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 253 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 254 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 255 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 256 ASIA - PACIFIC Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 257 ASIA - PACIFIC Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 258 ASIA - PACIFIC Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 259 ASIA - PACIFIC Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 260 ASIA - PACIFIC Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 261 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 262 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 263 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 264 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 265 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 266 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 267 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 268 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 269 CHINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 270 CHINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 271 CHINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 272 CHINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 273 CHINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 274 CHINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 275 CHINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 276 CHINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 277 CHINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 278 CHINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 279 CHINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 280 CHINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 281 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 282 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 283 JAPAN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 284 JAPAN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 285 JAPAN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 286 JAPAN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 287 JAPAN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 288 JAPAN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 289 JAPAN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 290 JAPAN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 291 JAPAN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 292 JAPAN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 293 JAPAN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 294 JAPAN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 295 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 296 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 297 INDIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 298 INDIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 299 INDIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 300 INDIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 301 INDIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 302 INDIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 303 INDIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 304 INDIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 305 INDIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 306 INDIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 307 INDIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 308 INDIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 309 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 310 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 311 AUSTRALIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 312 AUSTRALIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 313 AUSTRALIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 314 AUSTRALIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 315 AUSTRALIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 316 AUSTRALIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 317 AUSTRALIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 318 AUSTRALIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 319 AUSTRALIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 320 AUSTRALIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 321 AUSTRALIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 322 AUSTRALIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 323 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 324 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 325 SOUTH KOREA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 326 SOUTH KOREA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 327 SOUTH KOREA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 328 SOUTH KOREA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 329 SOUTH KOREA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 330 SOUTH KOREA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 331 SOUTH KOREA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 332 SOUTH KOREA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 333 SOUTH KOREA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 334 SOUTH KOREA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 335 SOUTH KOREA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 336 SOUTH KOREA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 337 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 338 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 339 SINGAPORE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 340 SINGAPORE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 341 SINGAPORE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 342 SINGAPORE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 343 SINGAPORE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 344 SINGAPORE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 345 SINGAPORE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 346 SINGAPORE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 347 SINGAPORE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 348 SINGAPORE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 349 SINGAPORE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 350 SINGAPORE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 351 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 352 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 353 THAILAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 354 THAILAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 355 THAILAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 356 THAILAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 357 THAILAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 358 THAILAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 359 THAILAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 360 THAILAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 361 THAILAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 362 THAILAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 363 THAILAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 364 THAILAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 365 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 366 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 367 MALAYSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 368 MALAYSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 369 MALAYSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 370 MALAYSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 371 MALAYSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 372 MALAYSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 373 MALAYSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 374 MALAYSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 375 MALAYSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 376 MALAYSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 377 MALAYSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 378 MALAYSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 379 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 380 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 381 INDONESIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 382 INDONESIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 383 INDONESIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 384 INDONESIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 385 INDONESIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 386 INDONESIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 387 INDONESIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 388 INDONESIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 389 INDONESIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 390 INDONESIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 391 INDONESIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 392 INDONESIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 393 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 394 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 395 PHILIPPINES Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 396 PHILIPPINES Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 397 PHILIPPINES Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 398 PHILIPPINES Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 399 PHILIPPINES Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 400 PHILIPPINES Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 401 PHILIPPINES Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 402 PHILIPPINES Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 403 PHILIPPINES Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 404 PHILIPPINES Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 405 PHILIPPINES Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 406 PHILIPPINES Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 407 rest of Asia - Pacific Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 408 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 409 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 410 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 411 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 412 SOUTH AMERICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 413 SOUTH AMERICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 414 SOUTH AMERICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 415 SOUTH AMERICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 416 SOUTH AMERICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 417 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 418 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 419 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 420 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 421 SOUTH AMERICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 422 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 423 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 424 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 425 BRAZIL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 426 BRAZIL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 427 BRAZIL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 428 BRAZIL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 429 BRAZIL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 430 BRAZIL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 431 BRAZIL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 432 BRAZIL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 433 BRAZIL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 434 BRAZIL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 435 BRAZIL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 436 BRAZIL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 437 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 438 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 439 ARGENTINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 440 ARGENTINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 441 ARGENTINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 442 ARGENTINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 443 ARGENTINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 444 ARGENTINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 445 ARGENTINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 446 ARGENTINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 447 ARGENTINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 448 ARGENTINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 449 ARGENTINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 450 ARGENTINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 451 rest of south america Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 452 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 453 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 454 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 455 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 456 MIDDLE EAST & AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 457 MIDDLE EAST & AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 458 MIDDLE EAST & AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 459 MIDDLE EAST & AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 460 MIDDLE EAST & AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 461 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 462 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 463 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 464 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 465 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 466 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 467 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 468 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 469 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 470 SOUTH AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 471 SOUTH AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 472 SOUTH AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 473 SOUTH AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 474 SOUTH AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 475 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 476 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 477 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 478 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 479 SOUTH AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 480 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 481 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 482 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 483 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 484 SAUDI ARABIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 485 SAUDI ARABIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 486 SAUDI ARABIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 487 SAUDI ARABIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 488 SAUDI ARABIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 489 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 490 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 491 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 492 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 493 SAUDI ARABIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 494 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 495 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 496 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 497 UAE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 498 UAE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 499 UAE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 500 UAE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 501 UAE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 502 UAE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 503 UAE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 504 UAE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 505 UAE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 506 UAE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 507 UAE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 508 UAE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 509 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 510 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 511 ISRAEL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 512 ISRAEL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 513 ISRAEL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 514 ISRAEL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 515 ISRAEL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 516 ISRAEL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 517 ISRAEL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 518 ISRAEL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 519 ISRAEL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 520 ISRAEL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 521 ISRAEL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 522 ISRAEL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 523 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 524 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 525 EGYPT Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 526 EGYPT Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 527 EGYPT Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 528 EGYPT Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 529 EGYPT Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 530 EGYPT Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 531 EGYPT Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 532 EGYPT Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 533 EGYPT Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 534 EGYPT Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 535 EGYPT Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 536 EGYPT Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 537 rest of MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

그림 목록

FIGURE 1 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation

FIGURE 3 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 Global prostate cancer diagnostics market: MARKET end users coverage GRID

FIGURE 10 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Global prostate cancer diagnostics market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE and asia-pacific is growing at the fastest pace in THE global prostate cancer diagnostics market IN the forecast period of 2021 to 2028

FIGURE 13 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE global Prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the global prostate cancer diagnostics MARKET in 2021 & 2028

FIGURE 15 asia-PACIFIC is the fastest growing market in global Prostate cancer diagnostics market in the forecast period of 2021 to 2028

FIGURE 16 REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET

FIGURE 18 ESTIMATED INCIDENCE CASES OF PROSTATE CANCER, ALL AGES

FIGURE 19 GERIATRIC POPULATION IN THE EUROPEAN REGION

FIGURE 20 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020

FIGURE 21 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020-2028 (USD Million)

FIGURE 22 global PROSTATE CANCER DIAGNOSTICS market: BY product type, CAGR (2021-2028)

FIGURE 23 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE

FIGURE 24 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, 2020

FIGURE 25 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE 2020-2028 (USD Million)

FIGURE 26 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, CAGR (2021-2028)

FIGURE 27 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, LIFELINE CURVE

FIGURE 28 Global prostate cancer diagnostics market: By type, 2020

FIGURE 29 Global prostate cancer diagnostics market: By type, 2020-2028 (USD Million)

FIGURE 30 Global prostate cancer diagnostics market: By type, CAGR (2020-2028)

FIGURE 31 Global prostate cancer diagnostics market: By type, LIFELINE CURVE

FIGURE 32 global PROSTATE CANCER DIAGNOSTICS market: BY age group, 2020

FIGURE 33 global PROSTATE CANCER DIAGNOSTICS market: BY age group , 2020-2028 (USD Million)

FIGURE 34 global PROSTATE CANCER DIAGNOSTICS market: BY age group, CAGR (2021-2028)

FIGURE 35 global PROSTATE CANCER DIAGNOSTICS market: BY age group, LIFELINE CURVE

FIGURE 36 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020

FIGURE 37 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020-2028 (USD Million)

FIGURE 38 global PROSTATE CANCER DIAGNOSTICS market: BY stage, CAGR (2021-2028)

FIGURE 39 global PROSTATE CANCER DIAGNOSTICS market: BY stage, LIFELINE CURVE

FIGURE 40 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020

FIGURE 41 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020-2028 (USD Million)

FIGURE 42 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, CAGR (2021-2028)

FIGURE 43 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, LIFELINE CURVE

FIGURE 44 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020

FIGURE 45 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020-2028 (USD Million)

FIGURE 46 global PROSTATE CANCER DIAGNOSTICS market: BY end users, CAGR (2021-2028)

FIGURE 47 global PROSTATE CANCER DIAGNOSTICS market: BY end users, LIFELINE CURVE

FIGURE 48 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020

FIGURE 49 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 50 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, CAGR (2021-2028)

FIGURE 51 global PROSTATE CANCER DIAGNOSTICS market: BY distribution, LIFELINE CURVE

FIGURE 52 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)

FIGURE 53 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)

FIGURE 54 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 55 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 56 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY pRODUCT type (2020-2028)

FIGURE 57 North America Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 58 North America Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 59 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 60 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 61 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 62 EUROPE Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 63 EUROPE Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 64 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 65 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 66 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 67 ASIA - PACIFIC Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 68 ASIA - PACIFIC Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 69 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 70 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 71 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 72 SOUTH AMERICA Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 73 SOUTH AMERICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 74 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 75 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 76 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 77 MIDDLE EAST & AFRICA Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 78 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 79 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 80 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 81 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 82 Global Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 83 north america Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 84 europe Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 85 Asia-Pacific Prostate cancer diagnostics market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The prostate cancer diagnostics market size will be worth USD 9.327.01 million by 2031.
The growth rate of the prostate cancer diagnostics market is 10.50% during the forecast period by 2031.
The increasing aging population & rising incidence of prostate cancer are the growth drivers of the prostate cancer diagnostics market.
Product type, diagnostics type, age group, type, stage, sample type, end-user, and distribution channel are the factors on which the prostate cancer diagnostics market research is based.
Major companies in the prostate cancer diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), HUMASIS (South Korea), Teco Diagnostics (U.S.), Hologic Inc. (U.S.), Accuquik Test Kits (U.S.), MDxHealthcare (Belgium), Abbott (U.S.), Siemens Healthcare GmbH (Germany), OPKO Health Inc. (U.S.), Myriad Genetics, Inc. (U.S.), DiaSorin S.p.A (Italy), Beckman Coulter, Inc. (a subsidiary of Danaher) (U.S.), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation) (U.S.), bioMérieux SA (France), Metamark Genetics, Inc. (U.S.), Prostatype Genomics (Switzerland), Fujirebio (Belgium), Proteomedix (Switzerland), Eurolyser Diagnostica GmbH (Austria).

관련 페이지 탐색

Banner